Found 34 matching trials
Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD
PHASE1Therapy of severe intestinal graft-versus-host disease (GVHD) despite the i...
Location
Pavlov First Saint-Petersburg State Medical University
A Study of FMT in Patients With AML Allo HSCT in Recipients
PHASE2This is a randomized, double-blind, placebo-controlled clinical trial of Fe...
Location
Masonic Cancer Center at University of Minnesota
Fecal Microbiota Transplantation in aGvHD After ASCT
PHASE3Acute graft-versus-host-disease (aGvHD) is a typical complication after all...
Location
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz
The IRMI-FMT Trial
NAAim of the study is to investigate the effect of Fecal Microbiota Transplan...
Location
Medical University of Graz
FMT for MS Patients
PHASE2This is a placebo-controlled, double-blinded, randomized trial design, wher...
Location
Multiple Locations
Autologous Fecal Microbiota Transplantation for Patients With Acute Graft-versus-Host Disease
NAThis study aims to assess the safety and efficacy of autologous fecal micro...
Location
Rambam Health Care Campus
Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study
NAThis is a single site pilot trial will evaluate the feasibility and safety ...
Location
University Health Network
Stool Transplantation for Treatment of Insulin Resistance in Morbidly Obese Patients
PHASE2More and more people in Canada and around the world are severely (morbidly)...
Location
University Health Network
The Effect of Fecal Microbiota Transplantation in Ankylosing Spondylitis (AS) Patients.
EARLY_PHASE1Ankylosing spondylitis (AS) patients often have subclinical gut wall inflam...
Location
Hospital District of Helsinki and Uusimaa, Department of Rheumatology
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
PHASE3MaaT013 showed interesting results in steroids and ruxolitinib-resistant aG...
Status
Active Not Recruiting
Location
Medizinische Universität Innsbruck